Gradileiden V Test
Test, Time, Partial Thromboplastin. 510(k) K992456, from Gradipore , Ltd. (North Ryde, AU). Product code GGW, class 2.
As of Nov 20, 2026, K992456 is an FDA 510(k) held by Gradipore , Ltd., substantially equivalent on Dec 21, 1999 after 151 days, with no recalls tied to it in FDA's recall database.
- Review time: 151 days
- Recalls: 0
- Cited as a predicate by: 2 devices
GradiLeiden V is a simple functional clotting test system intended for screening of resistance to Activated Protein C in plasma from individuals with the Factor V (Leiden) defect. It can also be performed on plasma from patients on stabilized oral anticoagulant or heparin therapy.
- Sysmex CS-5100K172333 · Siemens Healthcare Diagnostics Products GmbH · Oct 31, 2017
- Cryocheck Clot ApcrK060284 · Precision Biologic, Inc. · May 10, 2006
- HemosIL Factor V Leiden (APC Resistance V)K260551 · Instrumentation Laboratory (IL) Co. · Mar 20, 2026
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jul 23, 1999
- Review panel
- Hematology
- Regulation
- 21 CFR 864.7925
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files